- Filed
- Nov 4, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2025 · Sep 27, 2025 | 54.4M sh |
| Shares Diluted | Q3 2025 · Sep 27, 2025 | 54.7M sh |
| Shares Diluted | Q3 2025 · Sep 28, 2024 | 54.3M sh |
| Shares Diluted | Q3 2025 · Sep 28, 2024 | 54.3M sh |
| Shares Outstanding | Q3 2025 · Sep 27, 2025 | 53.71M sh |
| Stock Repurchased | Q3 2025 · Sep 27, 2025 | $177M |
| Stock Repurchased | Q3 2025 · Sep 28, 2024 | $0 |
| Capex | Q3 2025 · Sep 27, 2025 | $12.3M |
| Capex restated | Q3 2025 · Sep 28, 2024 | $14.9M |
| Operating Cash Flow | Q3 2025 · Sep 27, 2025 | $157.3M |
| Operating Cash Flow | Q3 2025 · Sep 28, 2024 | $145.9M |
| Long Term Debt | Q3 2025 · Sep 27, 2025 | $559.1M |
| Long Term Debt | Q3 2025 · Dec 28, 2024 | $714.3M |
| Short Term Debt | Q3 2025 · Sep 27, 2025 | $0 |
| Short Term Debt | Q3 2025 · Dec 28, 2024 | $15M |
| Cash And Equivalents | Q3 2025 · Sep 27, 2025 | $312.3M |
| Cash And Equivalents | Q3 2025 · Dec 28, 2024 | $123.6M |
| Stockholders Equity | Q3 2025 · Sep 27, 2025 | $810M |
| Stockholders Equity | Q3 2025 · Jun 28, 2025 | $1.04B |
| Stockholders Equity | Q3 2025 · Mar 29, 2025 | $946.4M |
| Stockholders Equity | Q3 2025 · Dec 28, 2024 | $1.05B |
| Stockholders Equity | Q3 2025 · Sep 28, 2024 | $1.46B |
| Stockholders Equity | Q3 2025 · Jun 29, 2024 | $1.37B |
| Stockholders Equity | Q3 2025 · Mar 30, 2024 | $1.37B |
| Stockholders Equity | Q3 2025 · Dec 30, 2023 | $1.36B |
| Current Liabilities | Q3 2025 · Sep 27, 2025 | $369.7M |
| Current Liabilities | Q3 2025 · Dec 28, 2024 | $617.7M |
| Total Liabilities | Q3 2025 · Sep 27, 2025 | $1.01B |
| Total Liabilities | Q3 2025 · Dec 28, 2024 | $1.57B |
| Current Assets | Q3 2025 · Sep 27, 2025 | $1.05B |
| Current Assets | Q3 2025 · Dec 28, 2024 | $1.23B |
| Total Assets | Q3 2025 · Sep 27, 2025 | $1.82B |
| Total Assets | Q3 2025 · Dec 28, 2024 | $2.63B |
| Eps Diluted | Q3 2025 · Sep 27, 2025 | −$1.84 |
| Eps Diluted | Q3 2025 · Sep 27, 2025 | −$4.01 |
| Eps Diluted | Q3 2025 · Sep 28, 2024 | $0.18 |
| Eps Diluted restated | Q3 2025 · Sep 28, 2024 | $0.83 |
| Eps Basic | Q3 2025 · Sep 27, 2025 | −$1.86 |
| Eps Basic | Q3 2025 · Sep 27, 2025 | −$4.06 |
| Eps Basic restated | Q3 2025 · Sep 28, 2024 | $0.19 |
| Eps Basic | Q3 2025 · Sep 28, 2024 | $0.84 |
| Sga Expense | Q3 2025 · Sep 27, 2025 | $116.4M |
| Sga Expense | Q3 2025 · Sep 27, 2025 | $374.7M |
| Sga Expense restated | Q3 2025 · Sep 28, 2024 | $136.6M |
| Sga Expense restated | Q3 2025 · Sep 28, 2024 | $378.5M |
| Rd Expense | Q3 2025 · Sep 27, 2025 | $30.5M |
| Rd Expense | Q3 2025 · Sep 27, 2025 | $94.3M |
| Rd Expense restated | Q3 2025 · Sep 28, 2024 | $37.3M |
| Rd Expense restated | Q3 2025 · Sep 28, 2024 | $114.2M |
| Net Income | Q3 2025 · Sep 27, 2025 | −$100.4M |
| Net Income | Q3 2025 · Sep 27, 2025 | −$219.8M |
| Net Income | Q3 2025 · Jun 28, 2025 | $51.3M |
| Net Income | Q3 2025 · Mar 29, 2025 | −$170.7M |
| Net Income | Q3 2025 · Sep 28, 2024 | $9.8M |
| Net Income | Q3 2025 · Sep 28, 2024 | $44.7M |
| Net Income | Q3 2025 · Jun 29, 2024 | $16M |
| Net Income | Q3 2025 · Mar 30, 2024 | $18.9M |
| Operating Income | Q3 2025 · Sep 27, 2025 | $83.6M |
| Operating Income | Q3 2025 · Sep 27, 2025 | $226.1M |
| Operating Income restated | Q3 2025 · Sep 28, 2024 | $38.2M |
| Operating Income restated | Q3 2025 · Sep 28, 2024 | $133.3M |
| Gross Profit | Q3 2025 · Sep 27, 2025 | $230.6M |
| Gross Profit | Q3 2025 · Sep 27, 2025 | $697.9M |
| Gross Profit restated | Q3 2025 · Sep 28, 2024 | $212.1M |
| Gross Profit restated | Q3 2025 · Sep 28, 2024 | $626M |
| Cost Of Revenue | Q3 2025 · Sep 27, 2025 | $140.9M |
| Cost Of Revenue | Q3 2025 · Sep 27, 2025 | $416.5M |
| Cost Of Revenue restated | Q3 2025 · Sep 28, 2024 | $131.2M |
| Cost Of Revenue restated | Q3 2025 · Sep 28, 2024 | $400.8M |
| Revenue | Q3 2025 · Sep 27, 2025 | $371.5M |
| Revenue | Q3 2025 · Sep 27, 2025 | $1.11B |
| Revenue restated | Q3 2025 · Sep 28, 2024 | $343.3M |
| Revenue restated | Q3 2025 · Sep 28, 2024 | $1.03B |